ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Goodwill

The premium paid for acquisitions above the fair value of the identifiable net assets acquired.

No reported Goodwill figures are available to summarize.

Goodwill history

Currency unavailable · from the balance sheet

No Goodwill data reported for this period type.

Goodwill vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Goodwill for ADRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SLNSilence Therapeutics plcMar 2026$10.36M USD+5.9%+9.9%9.0%
STOKStoke Therapeutics, Inc.Mar 2026$0 USD——0.0%
MGTXMeiraGTx Holdings plcMar 2026$0 USD——0.0%
PRMEPrime Medicine, Inc.Mar 2026$0 USD——0.0%
WVEWave Life Sciences Ltd.Mar 2026$0 USD——0.0%
BNTCBenitec Biopharma Inc.Mar 2026$0 USD——0.0%
ARCTArcturus Therapeutics Holdings Inc.Mar 2026$0 USD——0.0%
PRQRProQR Therapeutics N.V.Mar 2026€0 EUR——0.0%
RNAAtrium Therapeutics, Inc.Mar 2026$0 USD——0.0%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —+5.9%+9.9%0.0%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.